Immunodeficiences Flashcards

1
Q

what should a well-functioning immune system be able to?

A
  • recognize and destroy self and non-self entities that are causing harm (i.e pathogens or tumours)
  • ignore entities that are harmless (i.e consumed food)

barriers of the body that interact with the environment are important for this
–> lungs, GI tract, skin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is immunodeficiency?

A
  • is when a part of the immune system is weakened or impaired immune system that makes the body more susceptible to infections, certain vaccines may be less effective, and there is an increased risk of tumors
  • there are two types: primary and secondary
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is primary and secondary immunodeficiency?

A
  • primary = caused by a genetic or developmental defect, such as mutations in genes responsible for the immune response
  • secondary = caused by external agents, such as drugs, radiation, infectious agents
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are the characteristics of primary immunodeficiencies?

A
  • leads to increased infections and/or increase risk of tumour development
  • present at birth, but may not be detected until later in life when they cause symptoms
  • may manifest as an autoimmune disease
  • can affect innate or adaptive immune responses
  • typically are very rare
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the main factors that determine the consequences of a genetic mutation in primary immunodeficiency disorders (PIDs)?

A
  • most PIDs are caused by a single gene defect
  • the consequence of the immune gene mutation depends on:
    1) the role of the affected protein
    2) the nature of the mutation (prevent expression or protein function)
  • mutations that occur early stages of hematopoiesis (the process of blood cell formation) can disrupt every downstream step of immune cell development, leading to broad immune deficiencies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is combined immunodeficiencies (CIDs)?

A
  • CIDs are diseases that result in the absence of T cells or significant T cell function impairment combined with some impairment of the B
    cell response
    –> T cell mutations often lead to B cell impairment because TFH cells help B cells
    with activation, antibody production, class switching and affinity maturation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is severe combined immunodeficiency (SCID)?

A
  • severe, life-limiting condition
  • characterized by a lack of functional lymphocytes (T and B cells) causing severe impairment to immune system
  • This disease presents in early childhood with the following symptoms:
    1) Repeated viral infection from 2-3 months of age
    2) Susceptible to bacterial and fungal infections
    3) Diarrhea, failure to thrive, lung failure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

how is SCID treated?

A
  • aggressive, immediate treatment with bone marrow or hematopoietic stem cell transplant
  • Without treatment, infants with SCID usually die from infections within the first two years of life

–> With an early bone marrow transplant, frequent follow-up and prompt treatment for infections, survival rates are very good

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what are the 5 categories of defects causing SCID in humans?

A
  • reticular dysgenesis (RD) = defective differentiation of hematopoietic stem cells into myeloid and lymphoid cells
  • defective purine metabolism = leads to build up of toxic metabolites in B and T cells (impairs, weakens, kills lymphocytes)
  • defects in receptor rearrangement (RAG mutation) = leading to no VDJ recombination of TCRs and BCRs so no functional t-cells and b-cells develop
  • mutations in cytokine receptor signalling = failure of developing t-cells to receive survival signals
  • defects in t-cell signalling = lead to inability to signal through TCRs

all have different outcomes and spectrum of severity, but bone marrow transplant is the treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is agammaglobulinaemias?

A
  • a group of inherited immune disorders that cause severe antibody deficiencies in the blood
  • caused by defects in b-lymphocytes
  • have similar presentation to SCID and require a bone marrow transplant for treatment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is X-linked hyper-IgM syndrome?

A
  • a rare, inherited immune deficiency disease that affects mostly males
  • individuals have a defective CD40L or CD40
  • this results in no CD40/CD40L interaction = there is no co-stimulation signal (Signal 2) between T cells and B cells.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are the consequences of X-linked hyper-IgM syndrome?

A

1) impaired antibody production
- no class switching can occur so only IgM antibodies are produced in high amounts
- lack of IgG, IgA and IgE antibodies

2) no germinal centers
- B cells cannot form germinal centers, preventing efficient antibody affinity maturation

3) no memory b-cells
- Impaired production of memory B cells, leading to poor long-term immunity.

4) recurrent infections
- increased susceptibility to bacterial infections, as IgG (critical for opsonization and complement activation) is absent.

*IgM antibodies are still produced at high levels = B cell activation to T cell-independent antigens is unaffected

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what are other antibody-related deficiencies?

A
  • selective IgA Deficiency is the most common antibody-related deficiency
  • caused by IgA-expressing B cells failling to differentiate into plasma cells = leading to reduced or absent IgA production.
  • individuals may exhibit greater than normal susceptibilities to infections in the respiratory, intestinal and genitourinary tracts
  • it affects around 1 in 700 individuals but 70% are asymptomatic
  • symptoms can include: intestinal malabsorption, allergic disease and autoimmune disorders
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what are innate immune deficiencies?

A

conditions that occur when the body’s innate immune response to infection is delayed or impaired, primarily affecting phagocytes or the complement system
- phagocytic defects can result from:
(1) reduced number of phagocytes = less monocytes in the blood and macrophages in tissues
(2) defects in the phagocytic process = cell motility, binding to pathogen, failure in phagocytic process, defective intracellular killing mechanism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is chronic graulomatous disease (CGD)?

A
  • defect in NADPH oxidase, an enzyme required by phagocytes to produce reactive oxygen species (ROS)
  • this means they cannot effectively kill pathogens
    –> No NAPDH oxidase = no ROS/RNS = less effective pathogen killing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what are the consequences and treatment of chronic graulomatous disease (CGD)?

A
  • CGD patients are more susceptible to bacterial and fungal pathogens
  • inability to phagocytose causes granulomas (a build of dead cells) = excessive inflammatory responses

Treatment:
- antibiotics and anti-fungal drugs
- IFN-ɣ treatment can enhance macrophage phagocytosis and reduce inflammation

17
Q

what is the purpose of immune regulation?

A
  • the immune system must be able to distinguish self from non-self to avoid attacking the body’s own tissues
  • this regulation prevents responses to self-antigens, maintaining tolerance
    –> central tolerance is established in the thymus (for T cells) and bone marrow (for B cells).
    –> peripheral tolerance is maintained by T regulatory cells (Tregs), which suppress immune responses in peripheral tissues and prevent autoimmunity.
18
Q

what are immune regulation deficiencies?

A

refers to a group of disorders that occur when mutations disrupt the immune systems tolerance mechanisms, leading to immune dysregulation
- immune dysregulation can cause the immune system to attack the body’s own tissues, resulting in autoimmune diseases.
- some mutations directly affect T cell tolerance mechanisms.
- other mutations contribute to broader immune system dysfunctions, which can lead to autoimmune conditions

19
Q

what is Immune dysregulation,
polyendocrinophathy, enteropathy, X- linked
(IPEX)?

A
  • IPEX is caused by a genetic defect in the master regulator, FOXP3, which is essential for the development of Tregs.
  • Tregs actively inhibit reactions to self-antigens in the periphery.
  • in IPEX, regulatory T cells do not develop, leading to unchecked auto-reactive T cells that escape negative selection in the thymus.
  • this results in systemic autoimmune disease, where the immune system attacks the body’s own tissues.
  • individuals with IPEX do not survive past the age of two
20
Q

what are secondary immunodeficiences?

A

are acquired through by external agents such as drugs, radiation, infectious agents

other sources of secondary immunodeficiencies include:
- Immunosuppressive drug treatment (i.e chemotherapy, anti-transplant rejection)
- metabolic diseases and malnutrition

AIDS is the best studied example

21
Q

what are the impacts of secondary immunodeficiencies?

A
  • heightened susceptibility to common infectious agents, opportunistic infections and
    certain cancers
    -severity is dependent on the extent of immune suppression
22
Q

what is the most common cause of secondary immunodeficieny?

A
  • HIV

however, HIV is not the only pathogen that can suppress the immune response, many viruses have this capability

Why?
- viruses suppress the immune response to survive and continue replicating as pathogens.
- viruses are intracellular, allowing them to hide more effectively from the immune system.

23
Q

what is the virology of HIV?

A
  • HIV is an RNA virus and a retrovirus
  • HIV is one of the most mutable viruses on the planet, meaning it changes rapidly, which contributes to challenges in treatment and vaccine development.
24
Q

how is HIV transmitted?

A
  • HIV is a sexuallyy transmitted virus that preferentially infects CD4+ t-cells
  • the virus is present in vaginal secretions and semen, and both free (extracellular) and virus-infected cells can contribute to infection through the reproductive tract
  • In females, the initial site of infection is likely the vaginal mucosal epithelial layer, where resting memory CD4+ T cells are directly infected
  • an HIV-infected vaginal mucosa recruits more CD4+ T cells to the site of infection, increasing the number of target cells for the virus.
    –> if the individual has inflammation from other sexually transmitted diseases (STDs), it can further recruit CD4+ T cells, worsening the HIV infection.
25
Q

how does HIV get past the epithelial barrier?

A
  • physical damage (abrasions) to the epithelial layer during intercourse can create opening for the virus to enter
  • Free virus may squeeze through gaps between
    epithelial cells
  • Free virus may move through epithelial
    cells via transcytosis
  • intraepithelial dendritic cells can send dendrites into the lumen, when can get infected with HIV, and transport the virus to CD4+ T cells via an infectious synapse, facilitating the spread of the virus.
26
Q

what is the process of HIV infection?

A

HIV requires dual interaction to enter the host cell
- HIV uses its gp120 protein to bind to the CD4 receptor on the surface of host cells (primary interaction)
- After binding to CD4, gp120 also binds to one of two co-receptors (CXCR4 on t-cells or CCR5 on macrophages or dendritic cells)

27
Q

What factors contribute to the high mutation rate of HIV, and how does this affect the virus?

A

HIV has a high replicative capacity & error prone replication
- an infected individual can produce around 10^9 virus particles per day, which increases the chances for mutation.
- evirus particle replicates every two days, providing more opportunities for errors to occur.
–> therefore, HIV has an incredibly high mutation rate
–> you can have multiple versions of HIV in a single individual, and these versions mutate over time

28
Q

what are the 3 phases of HIV infection?

A

1) actue
2) chronic
3) profound immunosuppression (AIDS)

29
Q

overview of acute HIV infection phase 1

A
  • approximately 20% of patients experience symptoms and seek medical assistance, while most remain asymptomatic for extended periods (up to 10 years)
  • symptoms may appear 2-3 weeks after infection and include sore throat, lymphadenopathy (enlarged lymph nodes), malaise, and joint aches
  • patients are highly infectious
30
Q

what is the role of anti-retroviral therapy (ART) in those with HIV?

A
  • anti-retroviral therapy (ART) can keep individuals in their asymptomatic phase for years
  • ART can reduce viral load to zero, but the provirus remains in the host cell genome
  • due to ART, HIV/AIDS is now a manageable chronic disease, allowing individuals with the infection to have normal life spans.
  • HIV morbidity and mortality rates have decreased with the advent of ART
31
Q

what occurs in the immune system during acute HIV infection phase 1?

A
  • at this time, there is a massive increase in viral load, reaching 1,000,000 copies of HIV/mL of blood = acute viremia (high levels of virus in the blood stream)
  • there is a fast drop in CD4+ t-cells (approx. 50%) which can lead to immunodeficiency
  • seroconversion begins = individual produces antibodies against HIV and are found in the blood
  • viral set point is established = the stabilized viral load following the acute phase
32
Q

what occurs in chronic HIV infection phase 2?

A
  • HIV-specific immune responses (antibodies, CTLs) develop and partially control virus infection
  • viral load decreases to 20,000-60,000 copies/mL, but remains relatively stable
  • lymphoid tissue (nodes, spleen) contains a reservoir of infected macrophages and dendritic cells
    –> if untreated, CD4+ T cell numbers continue to decrease, leading to eventual immunodeficiency.
33
Q

what occurs in symptomatic/profound immunosuppression phase 3?

A
  • the balance between the immune response and HIV replication shifts, leading to an increase in HIV viral load (>120,000 copies/mL).
  • CD4+ T cell count drops below the normal limit (500 cells/mm³).
    –> when CD4+ T cell counts fall below 200 cells/mm³, there is an increased susceptibility to opportunistic infections
  • immunodeficiency develops, and typical infections include: Yeasts, Bacterial infections, Herpes simplex virus
  • tumours can develop, such as: Kaposi’s sarcoma, Non-Hodgkin’s lymphoma, invasive cervical carcinoma
34
Q

how is HIV diagnosed?

A
  • diagnosis of infection is confirmed by the presence of anti-HIV antibodies in the blood.
  • enzyme-linked immunosorbent assay (ELISA) is used to detect these antibodies.
  • seroconversion (the development of detectable antibodies) takes more than 2 months after infection, known as the HIV window.
  • some more sensitive tests may detect anti-HIV antibodies within ~3 weeks post-infection.
35
Q

what is the treatment for HIV infection?

A
  • since HIV integrates into its host’s genome, HIV infection cannot be cured
  • however, anti-retroviral drugs can inhibit virus replication
  • each individual is given a cocktail of at least three classes of antiretroviral drugs to take simultaneously
  • antiretroviral therapy (ART) is a combination of drugs that target different parts of HIV’s replication cycle
    –> ART can suppress viral load (<50 copes/mL, now even to undetectable levels)
36
Q

how does HIV evade the immune system?

A

HIV can mutate during the course of infection within an individual

one example is through MHC presentation:
- HLA B27 presents HIV epitopes with the sequence: KRWIILGLNE
- R at position 2 is the anchor residue
- HIV escapes CTL recognition by mutating R to K, T, or G
- This prevents the peptide from binding to HLA B27
- If the HIV peptide can’t bind to MHC class I, CD8+ T cells can’t recognize or activate the immune response

37
Q

is vaccination useful against HIV/AIDs?

A

HIV vaccination is really the only way to end HIV/AIDs however, there is not currently an effective vaccine

  • HIV mutation rates and resulting variability in strains is a major problem = designing a vaccine that targets all strains is very difficult
  • HLA molecules vary between individuals, which means that each person may present different HIV epitopes to their immune system = a single vaccine may not work equally well across all populations.

So the problem…which epitopes to include in the vaccine?